Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$6.6 - $7.8 $27,680 - $32,713
-4,194 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$5.76 - $8.95 $11,306 - $17,568
1,963 Added 87.99%
4,194 $29,000
Q4 2018

Feb 13, 2019

SELL
$5.26 - $7.97 $67,164 - $101,768
-12,769 Reduced 85.13%
2,231 $13,000
Q3 2018

Nov 13, 2018

BUY
$4.65 - $7.95 $69,750 - $119,250
15,000 New
15,000 $113,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.23B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.